BEST UNLIMITED TURBO SHORT CERTIFICATE - IPSEN | Market Closed - Euronext Paris 11:34:37 2024-05-31 EDT | ||
| 0.635 EUR | -7.30% |
|
| Current month | -36.82% | ||
| 1 month | -36.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.635 | -7.30% |
| 24-05-30 | 0.685 | -5.52% |
| 24-05-29 | 0.725 | -1.36% |
| 24-05-28 | 0.735 | +8.89% |
| 24-05-27 | 0.675 | +17.39% |
Real-time Euronext Paris
Last update May 31, 2024 at 11:34 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 7N84S | |
| ISIN | DE000SH7ZJF2 |
| Date issued | 2022-03-24 |
| Strike | 132.4 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.075 € |
|---|---|
| Lowest since issue | 0.215 € |
| Spread | 0.03 € |
| Spread % | 4.62% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
119.4
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.86%
- Stock Market
- Certificates
- 7N84S Certificat
